1. Home
  2. ENVB vs CREV Comparison

ENVB vs CREV Comparison

Compare ENVB & CREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • CREV
  • Stock Information
  • Founded
  • ENVB 1994
  • CREV 2007
  • Country
  • ENVB United States
  • CREV Ireland
  • Employees
  • ENVB N/A
  • CREV N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • CREV
  • Sector
  • ENVB Health Care
  • CREV
  • Exchange
  • ENVB Nasdaq
  • CREV Nasdaq
  • Market Cap
  • ENVB 4.1M
  • CREV 4.8M
  • IPO Year
  • ENVB N/A
  • CREV N/A
  • Fundamental
  • Price
  • ENVB $0.35
  • CREV $5.05
  • Analyst Decision
  • ENVB Strong Buy
  • CREV Strong Buy
  • Analyst Count
  • ENVB 1
  • CREV 1
  • Target Price
  • ENVB $10.00
  • CREV $39.00
  • AVG Volume (30 Days)
  • ENVB 1.0M
  • CREV 1.6M
  • Earning Date
  • ENVB 11-14-2024
  • CREV 01-01-0001
  • Dividend Yield
  • ENVB N/A
  • CREV N/A
  • EPS Growth
  • ENVB N/A
  • CREV N/A
  • EPS
  • ENVB N/A
  • CREV N/A
  • Revenue
  • ENVB N/A
  • CREV $39,261,077.00
  • Revenue This Year
  • ENVB N/A
  • CREV $40.76
  • Revenue Next Year
  • ENVB N/A
  • CREV $86.18
  • P/E Ratio
  • ENVB N/A
  • CREV N/A
  • Revenue Growth
  • ENVB N/A
  • CREV 41.52
  • 52 Week Low
  • ENVB $0.30
  • CREV $2.00
  • 52 Week High
  • ENVB $2.92
  • CREV $23.98
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 46.61
  • CREV 49.46
  • Support Level
  • ENVB $0.35
  • CREV $4.72
  • Resistance Level
  • ENVB $0.39
  • CREV $5.90
  • Average True Range (ATR)
  • ENVB 0.05
  • CREV 0.93
  • MACD
  • ENVB -0.00
  • CREV -0.24
  • Stochastic Oscillator
  • ENVB 19.56
  • CREV 6.98

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.

About CREV Carbon Revolution Public Limited

Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.

Share on Social Networks: